Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Clovis Oncology Inc CLVSQ

Healthcare Biotechnology
Clovis Oncology, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe and additional international markets. Its segments include U.S. and ex-U.S. Its product, Rubraca, is an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP) marketed in the United States for two indications... see more

Recent & Breaking News (PINL:CLVSQ)

Clovis Oncology Announces First Quarter 2013 Operating Results

Business Wire May 7, 2013

Clovis Oncology to Announce First Quarter 2013 Financial Results and Host Webcast Conference Call on May 7

Business Wire April 23, 2013

Free Research Reports on CLVS, GMXR, MDR and SBGI Issued by the Bedford Report

Marketwired March 4, 2013

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

Marketwired March 4, 2013

Clovis Oncology Announces 2012 Operating Results and 2013 Objectives

Business Wire February 28, 2013

Clovis Oncology to Present at the Cowen Health Care Conference in Boston

Business Wire February 25, 2013

Clovis Oncology to Announce Fourth Quarter/Year End 2012 Financial Results and Host Webcast Conference Call on February 28

Business Wire February 14, 2013

Clovis Oncology Announces 2013 Objectives and Financial Guidance

Business Wire January 7, 2013

Clovis Oncology to Present at the 31st Annual J.P. Morgan Healthcare Conference

Business Wire January 2, 2013